M L Schwandt
Overview
Explore the profile of M L Schwandt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schwandt M, Ramchandani V, Upadhyay J, Ramsden C, Diazgranados N, Goldman D
Alcohol
. 2024 Mar;
117:43-54.
PMID: 38537764
The relationship between pain and alcohol use disorder (AUD) is complex and bidirectional. The current study examines risk factors for pain in a large comprehensively phenotyped sample including individuals from...
2.
Klepp T, Sloan M, Soundararajan S, Ramsden C, Cinar R, Schwandt M, et al.
Alcohol
. 2022 Apr;
102:51-57.
PMID: 35452750
Chronic binge drinking induces hepatic lipid accumulation, but only certain individuals develop alcohol-associated liver disease (ALD). Specific patterns of lipid accumulation are thought to be associated with ALD, but this...
3.
Farokhnia M, Grodin E, Lee M, Oot E, Blackburn A, Stangl B, et al.
Mol Psychiatry
. 2017 Nov;
23(10):2029-2038.
PMID: 29133954
Preclinical evidence suggests that ghrelin, a peptide synthesized by endocrine cells of the stomach and a key component of the gut-brain axis, is involved in alcohol seeking as it modulates...
4.
Lindell S, Schwandt M, Suomi S, Rice K, Heilig M, Barr C
J Addict Behav Ther Rehabil
. 2017 Oct;
6(1).
PMID: 29082267
Background: Escalation of voluntary alcohol drinking is characteristic of alcohol addiction and can be induced in rodents using intermittent access to alcohol. This model has been used to evaluate candidate...
5.
Farokhnia M, Schwandt M, Lee M, Bollinger J, Farinelli L, Amodio J, et al.
Transl Psychiatry
. 2017 Apr;
7(4):e1108.
PMID: 28440812
Baclofen has been suggested as a potential pharmacotherapy for alcohol use disorder, but the clinical data are conflicting. Here we investigated the biobehavioral effects of baclofen in a sample of...
6.
Haass-Koffler C, Henry A, Melkus G, Simms J, Naemmuddin M, Nielsen C, et al.
Transl Psychiatry
. 2016 Nov;
6(11):e953.
PMID: 27845775
The corticotropin releasing factor (CRF) exerts its effects by acting on its receptors and on the binding protein (CRFBP), and has been implicated in alcohol use disorder (AUD). Therefore, identification...
7.
Suchankova P, Yan J, Schwandt M, Stangl B, Caparelli E, Momenan R, et al.
Transl Psychiatry
. 2015 Jun;
5:e583.
PMID: 26080318
The hormone glucagon-like peptide-1 (GLP-1) regulates appetite and food intake. GLP-1 receptor (GLP-1R) activation also attenuates the reinforcing properties of alcohol in rodents. The present translational study is based on...
8.
Ramchandani V, Umhau J, Pavon F, Ruiz-Velasco V, Margas W, Sun H, et al.
Mol Psychiatry
. 2010 May;
16(8):809-17.
PMID: 20479755
Excessive alcohol use, a major cause of morbidity and mortality, is less well understood than other addictive disorders. Dopamine release in ventral striatum is a common element of drug reward,...